Study Intended to Show That the VISTAKON Contact Lens is Safe and Effective for Use on an Extended-Wear Basis for up to 7 Days and 6 Nights at a Time.

This study has been completed.
Sponsor:
Information provided by:
Vistakon
ClinicalTrials.gov Identifier:
NCT00241280
First received: October 14, 2005
Last updated: January 30, 2009
Last verified: January 2009
  Purpose

Study in the US intended to show that the VISTAKON Contact Lens is safe and effective for use on an extended-wear basis for up to 7 days and 6 nights at a time


Condition Intervention
Myopia
Device: VISTAKON Contact Lens

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind

Resource links provided by NLM:


Further study details as provided by Vistakon:

Study Start Date: September 2005
Study Completion Date: October 2006
Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • At least 18 years of age
  • Minimum of 7 days of successful lens wear
  • Contact lens prescription requiring between -1.00 to -6.00 D spherical power
  • Less than 1.00 D of astigmatism in either eye

Exclusion Criteria:

-

  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00241280     History of Changes
Other Study ID Numbers: CR-1480
Study First Received: October 14, 2005
Last Updated: January 30, 2009
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Myopia
Refractive Errors
Eye Diseases

ClinicalTrials.gov processed this record on April 14, 2014